icd 10 cm code for junel fe

What is the ICD 10 code for urinalysis?

Z79.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2018/2019 edition of ICD-10-CM Z79.3 became effective on October 1, 2018. This is the American ICD-10-CM version of Z79.3 - other international versions of ICD-10 Z79.3 may differ.

What is the ICD 10 code for Z code?

Z79.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z79.3 became effective on October 1, 2021. This is the American ICD-10-CM version of Z79.3 - other international versions of ICD-10 Z79.3 may differ. Z codes represent reasons for encounters.

What is the ICD 10 code for excluded note?

E61.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM E61.1 became effective on October 1, 2021. This is the American ICD-10-CM version of E61.1 - other international versions of ICD-10 E61.1 may differ. A type 1 excludes note is a pure excludes.

What is the ICD 10 code for neonatal jaundice?

ICD 10 Codes for jaundice are located in different chapters in ICD book. ICD 10 Code for Neonatal jaundice are found in chapter 16 – conditions originating in perinatal period, code range P00 – P96 It is important to see the patient age and cause of jaundice in medical record to code to the highest specificity.

What is the ICD-10 code for birth control?

Z30. 9 - Encounter for contraceptive management, unspecified. ICD-10-CM.

What is the ICD-10 code for birth control refill?

Encounter for initial prescription of contraceptive pills Z30. 011 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z30. 011 became effective on October 1, 2021.

What is diagnosis code Z30 41?

Encounter for surveillance of contraceptive pillsICD-10 code Z30. 41 for Encounter for surveillance of contraceptive pills is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .

What is ICD-10 code Z30?

Encounter for contraceptive management2022 ICD-10-CM Diagnosis Code Z30: Encounter for contraceptive management.

What diagnosis is used for birth control?

Long term (current) use of hormonal contraceptives Z79. 3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z79. 3 became effective on October 1, 2021.

What is the CPT code for birth control pills?

Codes 99401-99404 are reported when the entire encounter is for preventive medicine counseling (contraceptive and/or STI).

What does Z01 419 include?

Instructions under Z01. 411 and Z01. 419 (routine gynecological exam with or without abnormal findings) indicate that the codes include a cervical Pap screening and instruct us to add additional codes for HPV screening and/or a vaginal Pap test.

How do I bill CPT code J1050?

The reimbursement rate for J1050 is $0.20 per unit (1mg). Since the code description is based on 1mg, providers should bill the applicable units based on the 1mg. Examples: A medroxyprogesterone acetate injection was given for 150 mg for contraceptive use.

What is the ICD 10 code for irregular menstruation?

6 Irregular menstruation, unspecified.

Is the Z30 09 billable?

Z30. 09 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z30. 09 became effective on October 1, 2021.

What is the ICD 10 code for acne?

ICD-10 code L70. 9 for Acne, unspecified is a medical classification as listed by WHO under the range - Diseases of the skin and subcutaneous tissue .

What is the ICD 10 code for removal of nexplanon?

Z30. 433 Encounter for removal and reinsertion of intrauterine contraceptive device in ICD-10-CM.

What is a type 1 exclude note?

A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as E61.1. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.

When will the ICD-10-CM E61.1 be released?

The 2022 edition of ICD-10-CM E61.1 became effective on October 1, 2021.

What is the code for newborn jaundice?

There are 4 categories of codes for newborn jaundice as per the cause – P55 (hemolytic disease), P57 (kernicterus), P58 (due to other hemolytic reasons) and P59 (Neonatal jaundice from other specified causes)

What happens if you leave jaundice untreated?

P57 – When jaundice is left untreated, number of bilirubin increases and it cause brain damage

What causes bilirubin to be more than liver capacity?

This is more than the liver capacity. Causes of prehepatic jaundice are thalassemia, sickle cell anemia, autoimmune disease and transfusion

What is the code for obstruction of bile duct?

Note: Obstructive jaundice should be coded to obstruction of bile duct K83.1

How long does it take for jaundice to heal?

New born jaundice gets cured after few days by exposing to light or sunlight which breaks down bilirubin and liver will start functioning normally. Jaundice in adult needs immediate medical care as it is a sign of an underlying disease such as:

Why is posthepatic obstructive?

Posthepatic – It is also called obstructive due to blockage of flow of bile into intestine.

Why does P55 breakdown occur?

This can happen due to the incompatibility of the blood groups or Rh factor in newborn and the mother.

What is the volume of distribution of norethindrone and ethinyl estradiol?

Volume of distribution of norethindrone and ethinyl estradiol ranges from 2 to 4 L/kg. Plasma protein binding of both steroids is extensive (>95%); norethindrone binds to both albumin and SHBG, whereas ethinyl estradiol binds only to albumin. Although ethinyl estradiol does not bind to SHBG, it induces SHBG synthesis.

How many cycles of Junel Fe 24?

In an active-controlled clinical trial, 743 women 18 to 45 years of age were studied to assess the efficacy of Junel Fe 24, for up to six 28-day cycles. The racial demographic of women randomized to Junel Fe 24 was: 69.5% Caucasian, 15.5% African-American, 10.4% Hispanic, 2.3% Asian and 2.3% Native American/Other. Women with body mass index (BMI) greater than 35 mg/m2 were excluded from the study. The weight range for those women treated was 90 to 260 pounds, with a mean weight of 147 pounds. Among the women in the study randomized to Junel Fe 24, 38.9% had not used hormonal contraception immediately prior to enrolling in this study.A total of 583 women completed 6 cycles of treatment. There were a total of 5 on-treatment pregnancies among women aged 18 to 45 years in 3,565 treatment cycles during which no back-up contraception was used. The Pearl Index for Junel Fe 24 was 1.82 (95% confidence interval 0.59 to 4.25).

What are the adverse reactions of COCs?

The following serious adverse reactions with the use of COCs are discussed elsewhere in the labeling:Serious cardiovascular events and stroke [see Boxed Warning and Warnings and Precautions (5.1)]Vascular events [see Warnings and Precautions (5.1)]Liver disease [see Warnings and Precautions (5.2)]Adverse reactions commonly reported by COC users are:Irregular uterine bleedingNauseaBreast tendernessHeadache

How to take Junel Fe 24?

Day 1 Start:Take first light yellow active tablet without regard to meals on the first day of menses.Take subsequent active tablets once daily at the same time each day for a total of 24 days.Take one brown inactive tablet daily for 4 days and at the same time of day that active tablets were taken.Be gin each subsequent pack on the same day of the week as the first cycle pack (i.e., on the day after taking the last inactive tablet). Sunday Start:For each 28-day course, take in the following order:Take the light yellow active tablet without regard to meals on the first Sunday after the onset of menses. Due to the potential risk of becoming pregnant, use additional non-hormonal contraception (such as condoms and spermicide) for the first 7 days of the patient’s first cycle pack of Junel Fe 24.Take subsequent active tablets once daily at the same time each day for a total of 24 days.Take one brown tablet (ferrous fumarate) daily for the following 4 days and at the same time of day that active tablets were taken. A scheduled period should occur during the 4 days that the brown tablets are taken.Begin each subsequent pack on the same day of the week as the first cycle pack (i.e., on the Sunday after taking the last inactive tablet) and additional non-hormonal contraceptive is not needed. Switching to Junel Fe 24 from another oral contraceptive Start on the same day that a new pack of the previous oral contraceptive would have started. Switching from another contraceptive method to Junel Fe 24 Start Junel Fe 24: Transdermal patch On the day when next application would have been scheduled. Vaginal ring On the day when next insertion would have been scheduled Injection On the day when next injection would have been scheduled Intrauterine contraceptive On the day of removal If the IUD is not removed on first day of the patient’s menstrual cycle, additional non-hormonal contraceptive (such as condoms and spermicide) is needed for the first seven days of the first cycle pack. Implant On the day of removal Complete instructions on proper tablet usage are located in the FDA-approved patient labeling.Starting Junel Fe 24 after Abortion or MiscarriageFirst-trimesterAfter a first-trimester abortion or miscarriage, Junel Fe 24 may be started immediately. An additional method of contraception is not needed if Junel Fe 24 is started immediately.If Junel Fe 24 is not started within 5 days after termination of the pregnancy, the patient must use additional non-hormonal contraception (such as condoms and spermicide) for the first 7 days of her first 28-day course of Junel Fe 24.Second-trimesterDo not start until 4 weeks after a second-trimester abortion or miscarriage, due to the increased risk of thromboembolic disease. Start Junel Fe 24 following the instructions in Table 1 for Sunday start. Use additional non-hormonal contraception (such as condoms and spermicide) for the first 7 days of the patient’s first 28-day course of Junel Fe 24 [see Contraindications (4), Warnings and Precautions (5.1), and FDA-approved Patient Labeling].Starting Junel Fe 24 after ChildbirthDo not start until 4 weeks after delivery, due to the increased risk of thromboembolic disease. Start contraceptive therapy with Junel Fe 24 following the instructions in Table 1 for women not currently using hormonal contraception.If the woman has not yet had a period postpartum, consider the possibility of ovulation and conception occurring prior to use of Junel Fe 24 [see Contraindications (4), Warnings and Precautions (5.1), Use in Specific Populations (8.1 and 8.3)].

What are the conditions that Junel Fe 24 is not prescribed for?

Do not prescribe Junel Fe 24 to women who are known to have the following conditions: A high risk of arterial or venous thrombotic diseases. Examples include women who are known to: Smoke, if over age 35 [see Boxed Warning and Warnings and Precautions (5.1)]Have deep vein thrombosis or pulmonary embolism, now or in the past [see Warnings and Precautions (5.1)]Have inherited or acquired hypercoagulopathies [see Warnings and Precautions (5.1)]Have cerebrovascular disease [see Warnings and Precautions (5.1)]Have coronary artery disease [see Warnings and Precautions (5.1)]Have thrombogenic valvular or thrombogenic rhythm diseases of the heart (for example, subacute bacterial endocarditis with valvular disease, or atrial fibrillation) [see Warnings and Precautions (5.1)]Have uncontrolled hypertension [see Warnings and Precautions (5.4)]Have diabetes mellitus with vascular disease [see Warnings and Precautions (5.6)]Have headaches with focal neurological symptoms or have migraine headaches with aura [see Warnings and Precautions (5.7)]Women over age 35 with any migraine headaches [see Warnings and Precautions (5.7)]Liver tumors, benign or malignant, or liver disease [see Warnings and Precautions (5.2)]Undiagnosed abnormal uterine bleeding [see Warnings and Precautions (5.8)]Pregnancy, because there is no reason to use COCs during pregnancy [see Warnings and Precautions (5.9) and Use in Specific Populations (8.1)]Breast cancer or other estrogen- or progestin-sensitive cancer, now or in the past [see Warnings and Precautions (5.11)]Use of Hepatitis C drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir, due to the potential for ALT elevations [see Warnings and Precautions (5.3)]

How does birth control work?

It works mainly by preventing the release of an egg (ovulation) during your menstrual cycle. It also makes vaginal fluid thicker to help prevent sperm from reaching an egg (fertilization) and changes the lining of the uterus (womb) to prevent attachment of a fertilized egg. If a fertilized egg does not attach to the uterus, it passes out of the body. There is a small amount of iron (ferrous fumarate) in each of the 7 inactive tablets taken during the fourth week. The inactive pills do not contain any hormones. These tablets are meant to keep you in the habit of taking 1 tablet each day and do not have enough iron to treat iron deficiency. Besides preventing pregnancy, birth control pills may make your periods more regular, decrease blood loss and painful periods, decrease your risk of ovarian cysts, and also treat acne. Using this medication does not protect you or your partner against sexually transmitted diseases (such as HIV, gonorrhea, chlamydia).

What drugs decrease COCs?

Some drugs or herbal products that may decrease the effectiveness of oral contraceptives including phenytoin, barbiturates, carbamazepine, bosentan, felbamate, griseofulvin, oxcarbazepine, rifampicin, topiramate, rifabutin, rufinamide, aprepitant, and products containing St. John’s wort. Interactions between COCs and other drugs may lead to breakthrough bleeding and/or contraceptive failure. Counsel women to use an alternative method of contraception or a back-up method when enzyme inducers are used with COCs, and to continue back-up contraception for 28 days after discontinuing the enzyme inducer to ensure contraceptive reliability.Substances increasing the plasma concentrations of COCs:Co-administration of atorvastatin or rosuvastatin and certain COCs containing ethinyl estradiol (EE) increase AUC values for EE by approximately 20 to 25%. Ascorbic acid and acetaminophen may increase plasma EE concentrations, possibly by inhibition of conjugation. CYP3A4 inhibitors such as itraconazole, voriconazole, fluconazole, grapefruit juice, or ketoconazole may increase plasma hormone concentrations.Human immunodeficiency virus (HIV)/Hepatitis C virus (HCV) protease inhibitors and non-nucleoside reverse transcriptase inhibitors:Significant changes (increase or decrease) in the plasma concentrations of estrogen and/or progestin have been noted in some cases of co-administration with HIV protease inhibitors (decrease [e.g., nelfinavir, ritonavir, darunavir/ritonavir, (fos)amprenavir/ritonavir, lopinavir/ritnoavir, and tipranavir/ritonavir] or increase [e.g., indinavir and atazanavir/ritonavir])/HCV protease inhibitors or with non-nucleoside reverse transcriptase inhibitors (decrease [e.g., nevirapine] or increase [e.g., etravirine]).